Genetic Testing Market by Product (Consumables & Equipment, Software & Services), Test Type (Carrier Testing, Diagnostic Testing, New Born Screening), Technology, Application, Distribution Channel, End-User - Global Forecast 2023-2030
The Genetic Testing Market is projected to reach USD 29.79 billion by 2030 from USD 10.45 billion in 2022, at a CAGR of 13.99% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Genetic Testing Market.
- Based on Product, market is studied across Consumables & Equipment and Software & Services. The Consumables & Equipment commanded largest market share of 85.88% in 2022, followed by Software & Services.
- Based on Test Type, market is studied across Carrier Testing, Diagnostic Testing, New Born Screening, Pharmacogenomics, Preimplantation Testing, Prenatal Testing, and Presymptomatic & Predictive Testing. The Pharmacogenomics commanded largest market share of 23.23% in 2022, followed by Diagnostic Testing.
- Based on Technology, market is studied across Cytogenetics, DNA Sequencing, Gene Expression Profiling, Microarrays, and PCR. The DNA Sequencing commanded largest market share of 29.23% in 2022, followed by Gene Expression Profiling.
- Based on Application, market is studied across Autoimmune Disorders, Cancer, Chronic Diseases, Genetic Disorders, and Neurodegenerative Diseases. The Genetic Disorders commanded largest market share of 32.12% in 2022, followed by Autoimmune Disorders.
- Based on Distribution Channel, market is studied across Offline and Online. The Offline commanded largest market share of 95.88% in 2022, followed by Online.
- Based on End-User, market is studied across Diagnostic Laboratories, Home Setting, and Hospitals & Clinics. The Diagnostic Laboratories commanded largest market share of 46.23% in 2022, followed by Hospitals & Clinics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.53% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Genetic Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Genetic Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., ELITechGroup SAS, Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Sanofi S.A., and Thermo Fisher Scientific Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Genetic Testing Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Genetic Testing Market?
- What is the competitive strategic window for identifying opportunities in the Genetic Testing Market?
- What are the latest technology trends and regulatory frameworks in the Genetic Testing Market?
- What is the market share of the leading vendors in the Genetic Testing Market?
- Which modes and strategic moves are suitable for entering the Genetic Testing Market?
Please Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Genetic Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of genetic and oncology disorders and need for precision medicine
- 5.1.1.2. Government initiatives for genetic testing and rise of self-test kits
- 5.1.2. Restraints
- 5.1.2.1. Concerns associated with false positives & negatives of genetic tests
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing research and new developments in genetic testing technologies
- 5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
- 5.1.4. Challenges
- 5.1.4.1. Logistical barriers and privacy concerns to genetic testing
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Penetration of software and services for efficient data management and analysis
- 5.2.2. Test Type: Emphasis on diagnostic testing to perform particular disease dignosis
- 5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
- 5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
- 5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
- 5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
- 5.3. Market Trend Analysis
- 5.3.1. Technological advances and presence of established pharmaceutical companies enhance the genetic testing market growth in the Americas
- 5.3.2. Increasing chronic disorders and expanding healthcare infrastructure supports genetic testing in the APAC region.
- 5.3.3. Government initiatives and increasing demand for personalized medicine expand genetic testing market growth in the EMEA region.
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Genetic Testing Market, by Product
- 6.1. Introduction
- 6.2. Consumables & Equipment
- 6.3. Software & Services
- 7. Genetic Testing Market, by Test Type
- 7.1. Introduction
- 7.2. Carrier Testing
- 7.3. Diagnostic Testing
- 7.4. New Born Screening
- 7.5. Pharmacogenomics
- 7.6. Preimplantation Testing
- 7.7. Prenatal Testing
- 7.8. Presymptomatic & Predictive Testing
- 8. Genetic Testing Market, by Technology
- 8.1. Introduction
- 8.2. Cytogenetics
- 8.3. DNA Sequencing
- 8.4. Gene Expression Profiling
- 8.5. Microarrays
- 8.6. PCR
- 9. Genetic Testing Market, by Application
- 9.1. Introduction
- 9.2. Autoimmune Disorders
- 9.3. Cancer
- 9.4. Chronic Diseases
- 9.5. Genetic Disorders
- 9.6. Neurodegenerative Diseases
- 10. Genetic Testing Market, by Distribution Channel
- 10.1. Introduction
- 10.2. Offline
- 10.3. Online
- 11. Genetic Testing Market, by End-User
- 11.1. Introduction
- 11.2. Diagnostic Laboratories
- 11.3. Home Setting
- 11.4. Hospitals & Clinics
- 12. Americas Genetic Testing Market
- 12.1. Introduction
- 12.2. Argentina
- 12.3. Brazil
- 12.4. Canada
- 12.5. Mexico
- 12.6. United States
- 13. Asia-Pacific Genetic Testing Market
- 13.1. Introduction
- 13.2. Australia
- 13.3. China
- 13.4. India
- 13.5. Indonesia
- 13.6. Japan
- 13.7. Malaysia
- 13.8. Philippines
- 13.9. Singapore
- 13.10. South Korea
- 13.11. Taiwan
- 13.12. Thailand
- 13.13. Vietnam
- 14. Europe, Middle East & Africa Genetic Testing Market
- 14.1. Introduction
- 14.2. Denmark
- 14.3. Egypt
- 14.4. Finland
- 14.5. France
- 14.6. Germany
- 14.7. Israel
- 14.8. Italy
- 14.9. Netherlands
- 14.10. Nigeria
- 14.11. Norway
- 14.12. Poland
- 14.13. Qatar
- 14.14. Russia
- 14.15. Saudi Arabia
- 14.16. South Africa
- 14.17. Spain
- 14.18. Sweden
- 14.19. Switzerland
- 14.20. Turkey
- 14.21. United Arab Emirates
- 14.22. United Kingdom
- 15. Competitive Landscape
- 15.1. FPNV Positioning Matrix
- 15.2. Market Share Analysis, By Key Player
- 15.3. Competitive Scenario Analysis, By Key Player
- 15.3.1. Merger & Acquisition
- 15.3.1.1. Sema4 to acquire genetic testing firm GeneDx for USD 623 Million
- 15.3.1.2. healthŌme Acquires Kailos Genetics
- 15.3.1.3. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
- 15.3.2. Agreement, Collaboration, & Partnership
- 15.3.2.1. Scribe and Sanofi expand genetic therapy development deal
- 15.3.2.2. CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
- 15.3.2.3. Invitae Announces Partnership with Epic to Streamline Genetic Testing
- 15.3.3. New Product Launch & Enhancement
- 15.3.3.1. Devyser launches two new genetic testing solutions for hereditary cancer
- 15.3.3.2. Blueprint Genetics introduces the new Screening Tests family; giving actionable insights for family planning, and future health
- 15.3.3.3. Kindbody Brings Genetic Testing In-House with the Launch of Kindlabs
- 15.3.3.4. PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors
- 15.3.4. Investment & Funding
- 15.3.4.1. DNA company Asa Ren raises USD 8M and more briefs
- 15.3.4.2. Genetic Testing Firm Delve Gets USD 35 Million in VC Funding
- 15.3.5. Award, Recognition, & Expansion
- 15.3.5.1. FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
- 15.3.5.2. MapMyGenome launches India’s First DNA Test For Personalized Skin And Hair Care
- 15.3.5.3. Grand Launching Of DNATEST.ID, A Comprehensive Dna Test In Indonesia
- 15.3.5.4. MyHeritage Releases cM Explainer to Predict Familial Relationships Between DNA Matches with Greater Accuracy
- 16. Competitive Portfolio
- 16.1. Key Company Profiles
- 16.1.1. Abbott Laboratories
- 16.1.2. Agilent Technologies, Inc.
- 16.1.3. Becton, Dickinson and Company
- 16.1.4. Bio-Rad Laboratories, Inc.
- 16.1.5. Blueprint Genetics Oy
- 16.1.6. Centogene N.V.
- 16.1.7. Color Health, Inc.
- 16.1.8. CooperSurgical Inc.
- 16.1.9. Editas Medicine, Inc.
- 16.1.10. ELITechGroup SAS
- 16.1.11. Eugene Labs Pty Ltd.
- 16.1.12. Eurofins Scientific SE
- 16.1.13. F. Hoffmann-La Roche AG
- 16.1.14. Fulgent Genetics, Inc.
- 16.1.15. Gene by Gene, Ltd.
- 16.1.16. GeneDx, LLC
- 16.1.17. Illumina, Inc.
- 16.1.18. Invitae Corporation
- 16.1.19. Laboratory Corporation of America Holdings
- 16.1.20. Living DNA Ltd.
- 16.1.21. Macrogen, Inc.
- 16.1.22. MyHeritage Ltd.
- 16.1.23. Myriad Genetics, Inc.
- 16.1.24. Natera, Inc.
- 16.1.25. Newtopia Inc.
- 16.1.26. PathogenDx Corporation
- 16.1.27. PerkinElmer Inc.
- 16.1.28. Qiagen N.V.
- 16.1.29. Sanofi S.A.
- 16.1.30. Thermo Fisher Scientific Inc.
- 16.2. Key Product Portfolio
- 17. Appendix
- 17.1. Discussion Guide
- 17.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook